Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
Steven H J Hageman, Lisa Pennells, Francisco Ojeda, et al.
European Heart Journal (2021) Vol. 42, Iss. 25, pp. 2439-2454
Open Access | Times Cited: 926

Showing 1-25 of 926 citing articles:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4190
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4073
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1452
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 782
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 625
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 370
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, et al.
European Heart Journal (2024) Vol. 45, Iss. 36, pp. 3415-3537
Open Access | Times Cited: 370
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions
Tamar I. de Vries, Marie Therese Cooney, Randi Selmer, et al.
European Heart Journal (2021) Vol. 42, Iss. 25, pp. 2455-2467
Open Access | Times Cited: 360
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Christina Magnussen, Francisco Ojeda, Darryl P. Leong, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 14, pp. 1273-1285
Open Access | Times Cited: 322
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 234
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Giovanni Targher, Christopher D. Byrne, Herbert Tilg
Gut (2024), pp. gutjnl-330595
Open Access | Times Cited: 220
Metabolomic profiles predict individual multidisease outcomes
Thore Buergel, Jakob Steinfeldt, Greg Ruyoga, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2309-2320
Open Access | Times Cited: 214
Development and Validation of the American Heart Association’s PREVENT Equations
Sadiya S. Khan, Kunihiro Matsushita, Yingying Sang, et al.
Circulation (2023) Vol. 149, Iss. 6, pp. 430-449
Closed Access | Times Cited: 191
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
Vera Regitz‐Zagrosek, Cathérine Gebhard
Nature Reviews Cardiology (2022) Vol. 20, Iss. 4, pp. 236-247
Open Access | Times Cited: 147
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
Nathan D. Wong, Matthew J. Budoff, Keith C. Ferdinand, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100335-100335
Open Access | Times Cited: 144
The artificial sweetener erythritol and cardiovascular event risk
Marco Witkowski, Ina Nemet, Hassan S. Alamri, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 710-718
Open Access | Times Cited: 120
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe
Lisa Pennells, Stephen Kaptoge, Helena Bleken Østergaard, et al.
European Heart Journal (2023) Vol. 44, Iss. 28, pp. 2544-2556
Open Access | Times Cited: 117
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts
Iain S. Forrest, Ben Omega Petrazzini, Áine Duffy, et al.
The Lancet (2022) Vol. 401, Iss. 10372, pp. 215-225
Open Access | Times Cited: 97
Disorders of lipid metabolism. Clinical Guidelines 2023
М. В. Ежов, В. В. Кухарчук, И. В. Сергиенко, et al.
Russian Journal of Cardiology (2023) Vol. 28, Iss. 5, pp. 5471-5471
Open Access | Times Cited: 96
Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment
Norbert Stefan, Matthias B. Schulze
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 6, pp. 426-440
Closed Access | Times Cited: 95
Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease
Maarten van Smeden, Georg Heinze, Ben Van Calster, et al.
European Heart Journal (2022) Vol. 43, Iss. 31, pp. 2921-2930
Open Access | Times Cited: 94
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Jeanine E. Roeters van Lennep, Lâle Tokgözoğlu, Lina Badimón, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4157-4173
Open Access | Times Cited: 81
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 24, pp. 2383-2397
Open Access | Times Cited: 80
2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2022) Vol. 21, Iss. 4, pp. 3235-3235
Open Access | Times Cited: 79
Retinal vessel diameters and function in cardiovascular risk and disease
Henner Hanssen, Lukas Streese, Walthard Vilser
Progress in Retinal and Eye Research (2022) Vol. 91, pp. 101095-101095
Open Access | Times Cited: 74
Page 1 - Next Page

Scroll to top